Product Description: Ravuconazole (BMS-207147;ER-30346) is an orally available triazole antifungle agent that potently inhibits a wide range of fungi.
Applications: COVID-19-immunoregulation
Formula: C22H17F2N5OS
References: [1]Hata K, et al. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.Antimicrob Agents Chemother. 1996 Oct;40(10):2237-42./[2]Fung-Tomc JC, et al. In vitro activity of a new oral triazole, BMS-207147 (ER-30346)Antimicrob Agents Chemother. 1998 Feb;42(2):313-8./[3]Hata K, et al. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.Antimicrob Agents Chemother. 1996 Oct;40(10):2243-7.
CAS Number: 182760-06-1
Molecular Weight: 437.47
Compound Purity: 99.91
Research Area: Infection; Cancer
Solubility: DMSO : ≥ 50 mg/mL
Target: Fungal
Deutsch
English
